Our scope includes primary and secondary prevention, acute treatment and rehabilitation. We cover all forms of heart disease, including ischaemic heart disease, arrhythmias, congenital heart diseases. 

Our reviews draw on sources of evidence from randomised controlled trials (RCTs). Occasionally, RCTs of quasi-experimental designs are used in topics concerned with public health policy and practice where RCTs are inappropriate tests of the efficacy of community level interventions. 

We currently prioritise reviews which:

  • cover a heart disease with a considerable global burden, eg affects many people;
  • are relevant to low and middle income countries;
  • aim to address a gap in the evidence as identified by national and international guidelines;
  • are conducted as part of a grant application for a clinical trial.